全部

1·The Control group received no ambroxol treatment.

对照组不使用沐舒坦。

2·Objective: To develop an HPLC method for assay of ambroxol hydrochloride.

目的：建立盐酸氨溴索的HPLC含量测定方法。

3·Objective: To study the predictive effect of ambroxol on acute lung injury.

目的研究沐舒坦对急性肺损伤的肺保护作用。

4·Objectives: To observe the effect of ambroxol hydrochloride on chronic bronchitis after surgery.

前言： 目的：观察盐酸氨溴索（沭舒坦）对慢性支气管炎（慢支）患者术后的疗效。

5·Objective: to study the effect of ambroxol as a bronchodilator on infants with wheezing disease.

目的：研究盐酸氨溴索对喘息小儿肺功能的影响。

6·Objective: To study the in vitro release rate of ambroxol HCl osmotic pump controlled release tablets.

前言：目的：研究盐酸氨溴索渗透泵控释片的体外释放度。

7·AIM: To investigate the effect of ambroxol on pulmonary and vascular injury in chronically hypoxic rats.

目的：探讨氨溴索对低氧性肺动脉高压大鼠慢性肺损伤的对抗作用。

8·A rapid identification system for ambroxol tablets from different manufacturers using NIR was developed.

采用近红外光谱定性分析法对不同厂家的盐酸氨溴索片进行快速识别。

9·CONCLUSION HPMC could be used as a matrix to prepare sustained-release tablet of ambroxol hydrochloride.

结论用羟丙甲基纤维素作为骨架材料能达到较好的缓释作用。

10·Conclusion Inhaled ambroxol hydrochloride and budesonide suspension treatment has be well effect in NRDS.

结论盐酸氨溴索、布地奈德混悬液氧气驱动雾化吸入防治NRDS有较好疗效。

氨溴索

1·Objective: To study the in vitro release rate of ambroxol HCl osmotic pump controlled release tablets.

前言：目的：研究盐酸氨溴索渗透泵控释片的体外释放度。

2·Objective: To develop an HPLC method for assay of ambroxol hydrochloride.

目的：建立盐酸氨溴索的HPLC含量测定方法。

3·Methods: 18 guinea-pigs were randomized into normal control group, bronchial asthma group and ambroxol group.

方法18只豚鼠随机分为正常对照组、哮喘模型组、氨溴索组。

4·Conclusion Aerosol inhalation of budesonide combined with ambroxol in treatment of acute exacerbation of COPD has good efficacy, no adverse reactions, is worthy of clinical use.

结论布地奈德联合氨溴索雾化吸入治疗COPD急性加重期疗效好，无明显不良反应，值得临床推广使用。

5·OBJECTIVE To observe the clinical effects of ambroxol hydrochloride combined with 654-2 in treatment with capillary tracheitis.

目的观察盐酸氨溴索联合654-2佐治毛细气管炎的临床疗效。